Mechanisms of a novel regulatory light chain–dependent cardiac myosin inhibitor
Journal of General Physiology · 2024
DOI: 10.1085/jgp.202313503 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of General Physiology, 2024. Verfasst von Kristina Kooiker und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, Medicine, University of Washington, Seattle, WA, USA. Hauptthemen laut MEDLINE: Myocardial Contraction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: U.S. Department of Energy, NHLBI NIH HHS, NIAMS NIH HHS.
Abstract (Originalsprache)
Hypertrophic cardiomyopathy (HCM) is a genetic disease of the heart characterized by thickening of the left ventricle (LV), hypercontractility, and impaired relaxation. HCM is caused primarily by heritable mutations in sarcomeric proteins, such as β myosin heavy chain. Until recently, medications in clinical use for HCM did not directly target the underlying contractile changes in the sarcomere. Here, we investigate a novel small molecule, RLC-1, identified in a bovine cardiac myofibril high-throughput screen. RLC-1 is highly dependent on the presence of a regulatory light chain to bind to cardiac myosin and modulate its ATPase activity. In demembranated rat LV trabeculae, RLC-1 decreased maximal Ca2+-activated force and Ca2+ sensitivity of force, while it increased the submaximal rate constant for tension redevelopment. In myofibrils isolated from rat LV, both maximal and submaximal Ca2+-activated force are reduced by nearly 50%. Additionally, the fast and slow phases of relaxation were approximately twice as fast as DMSO controls, and the duration of the slow phase was shorter. Structurally, x-ray diffraction studies showed that RLC-1 moved myosin heads away from the thick filament backbone and decreased the order of myosin heads, which is different from other myosin inhibitors. In intact trabeculae and isolated cardiomyocytes, RLC-1 treatment resulted in decreased peak twitch magnitude and faster activation and relaxation kinetics. In conclusion, RLC-1 accelerated kinetics and decreased force production in the demembranated tissue, intact tissue, and intact whole cells, resulting in a smaller cardiac twitch, which could improve the underlying contractile changes associated with HCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, Medicine, University of Washington, Seattle, WA, USA.
- Center of Translational Muscle Research, University of Washington , Seattle, WA, USA.
- Center for Cardiovascular Biology, University of Washington , Seattle, WA, USA.
- Institute for Stem Cell and Regenerative Medicine, University of Washington , Seattle, WA, USA.
- Bristol Myers Squibb Research , Brisbane, CA, USA.
- Department of Bioengineering, University of Washington, Seattle, WA, USA.
ORCID-Profile: Kristina Kooiker, Qing-Fen Gan, Ming Yu, Na Sa, Saffie Mohran, Yuanhua Cheng, Galina Flint, Stephanie Neys, Chengqian Gao, Devin Nissen, Tim McMillen, Anthony Asencio, Weikang Ma, Thomas C Irving, Farid Moussavi-Harami, Michael Regnier
Förderung
- U.S. Department of Energy
- NHLBI NIH HHS
- NIAMS NIH HHS
- Bristol Myers Squibb
- NIBIB NIH HHS
- NIH HHS
- NIGMS NIH HHS
- University of Washington
Zitieren
APA
Kooiker, K., Gan, Q. F., Yu, M., Sa, N., Mohran, S., Cheng, Y., Flint, G., Neys, S., Gao, C., Nissen, D., McMillen, T., Asencio, A., Ma, W., Irving, T. C., Moussavi-Harami, F., & Regnier, M. (2024). Mechanisms of a novel regulatory light chain–dependent cardiac myosin inhibitor. Journal of General Physiology. https://doi.org/10.1085/jgp.202313503
Vancouver
Kooiker K, Gan QF, Yu M, Sa N, Mohran S, Cheng Y, et al. Mechanisms of a novel regulatory light chain–dependent cardiac myosin inhibitor. Journal of General Physiology. 2024. doi:10.1085/jgp.202313503
BibTeX
@article{Kooiker2024,
author = {Kooiker, Kristina and Gan, Qing-Fen and Yu, Ming and Sa, Na and Mohran, Saffie and Cheng, Yuanhua and Flint, Galina and Neys, Stephanie and Gao, Chengqian and Nissen, Devin and McMillen, Tim and Asencio, Anthony and Ma, Weikang and Irving, Thomas C and Moussavi-Harami, Farid and Regnier, Michael},
title = {Mechanisms of a novel regulatory light chain–dependent cardiac myosin inhibitor},
journal = {Journal of General Physiology},
year = {2024},
doi = {10.1085/jgp.202313503}
}
EUVIMED